AVLN

Avalyn Pharma Inc.

$30.49

+4.03% vs $29.31

Mkt Cap $1.4B

52w Low $24.15 78.5% of range 52w High $32.23

50d MA $28.28 200d MA $28.28

P/E (TTM) —

EV/EBITDA —

P/B —

Debt/Equity —

ROE —

P/FCF —

RSI (14) 53.80

ATR (14) $2.78

Beta —

50d MA $28.28

200d MA $28.28

Avg Volume —

CIK (SEC)

1540171

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 26	Evercore ISI	Initiates	Outperform	$51	$28.84	$29.68	+2.9%	-7.4%	+0.4%	+5.9%	+1.4%	-7.4%
May 26	Guggenheim	Initiates	Buy	$80	$28.84	$29.68	+2.9%	-7.4%	+0.4%	+5.9%	+1.4%	-7.4%
May 26	Jefferies	Initiates	Buy	$52	$28.84	$29.68	+2.9%	-7.4%	+0.4%	+5.9%	+1.4%	-7.4%
May 26	Morgan Stanley	Initiates	Overweight	$53	$28.84	$29.68	+2.9%	-7.4%	+0.4%	+5.9%	+1.4%	-7.4%

Date	Insider	Title	Type	Shares	Price	Value	Owned After	D1%	D5%
May 1, 2026	Novo Holdings A/S	—	Buy	555,555	$18.00	$10.0M	3,883,289	+1.02%	+1.12%
May 1, 2026	SR ONE CAPITAL MANAGEMENT, LLC	—	Buy	277,777	$18.00	$5.0M	1,122,087	-2.58%	+1.49%
May 1, 2026	SR ONE CAPITAL MANAGEMENT, LLC	—	Buy	277,778	$18.00	$5.0M	2,186,562	-2.58%	+1.49%
May 1, 2026	Carroll Jill	—	Buy	277,778	$18.00	$5.0M	2,186,562	-2.58%	+1.49%

Institutional (13F) — Top 0 All ↗

No 13F holders found.

Mutual Funds / ETFs (N-PORT) — Top 1 All ↗

#	Fund	Shares	Value	Period
1	Global Bond Fund	436,000	$504K	Mar 2026

· Source: financialmodelingprep.com